Year: 2021

news_6

EdCast Releases Learning Health Index Report 2021 in Conjunction with Mercer, NSE Academy and People Matters: Study Shows That Most Companies’ Learning Ecosystems Have Significant Room to Improve

news_6

Celltrion Healthcare Presents Positive One-Year Data for the First High-Concentration, Low-Volume and Citrate-Free Biosimilar Adalimumab, YuflymaTM (CT-P17) in Patients With Rheumatoid Arthritis at EULAR 2021

One-year data have shown equivalent efficacy and comparable safety for Yuflyma™ (CT-P17) against reference adalimumab in patients with moderate-to-severe active...